A detailed history of Financial Advocates Investment Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Financial Advocates Investment Management holds 15,111 shares of GILD stock, worth $1.42 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,111
Previous 14,446 4.6%
Holding current value
$1.42 Million
Previous $991,000 27.75%
% of portfolio
0.07%
Previous 0.06%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$66.59 - $83.99 $44,282 - $55,853
665 Added 4.6%
15,111 $1.27 Million
Q2 2024

Jul 26, 2024

BUY
$63.15 - $72.88 $348,966 - $402,734
5,526 Added 61.95%
14,446 $991,000
Q1 2024

May 01, 2024

BUY
$71.58 - $87.29 $52,181 - $63,634
729 Added 8.9%
8,920 $653,000
Q4 2023

Feb 08, 2024

BUY
$73.27 - $83.09 $22,567 - $25,591
308 Added 3.91%
8,191 $663,000
Q3 2023

Oct 27, 2023

BUY
$73.94 - $80.67 $20,851 - $22,748
282 Added 3.71%
7,883 $590,000
Q2 2023

Aug 07, 2023

SELL
$76.01 - $86.7 $72,285 - $82,451
-951 Reduced 11.12%
7,601 $585,000
Q1 2023

May 11, 2023

SELL
$77.31 - $88.08 $173,406 - $197,563
-2,243 Reduced 20.78%
8,552 $709,000
Q4 2022

Feb 14, 2023

BUY
$62.32 - $89.47 $385,511 - $553,461
6,186 Added 134.22%
10,795 $926,000
Q3 2022

Nov 14, 2022

SELL
$59.54 - $68.01 $315,264 - $360,112
-5,295 Reduced 53.46%
4,609 $275,000
Q2 2022

Aug 12, 2022

BUY
$57.72 - $65.01 $156,940 - $176,762
2,719 Added 37.84%
9,904 $612,000
Q1 2022

May 11, 2022

BUY
$57.92 - $72.58 $164,782 - $206,490
2,845 Added 65.55%
7,185 $427,000
Q4 2021

Feb 14, 2022

SELL
$64.88 - $73.64 $186,659 - $211,862
-2,877 Reduced 39.86%
4,340 $321,000
Q3 2021

Nov 04, 2021

BUY
$67.69 - $73.03 $148,782 - $160,519
2,198 Added 43.79%
7,217 $504,000
Q2 2021

Aug 03, 2021

SELL
$63.47 - $69.35 $114,563 - $125,176
-1,805 Reduced 26.45%
5,019 $347,000
Q1 2021

May 10, 2021

BUY
$60.0 - $68.46 $5,280 - $6,024
88 Added 1.31%
6,824 $441,000
Q4 2020

Feb 12, 2021

BUY
$56.65 - $64.55 $84,125 - $95,856
1,485 Added 28.28%
6,736 $393,000
Q3 2020

Nov 04, 2020

BUY
$62.1 - $78.08 $26,703 - $33,574
430 Added 8.92%
5,251 $332,000
Q2 2020

Aug 14, 2020

SELL
$72.34 - $84.0 $102,071 - $118,524
-1,411 Reduced 22.64%
4,821 $371,000
Q1 2020

Apr 29, 2020

BUY
$62.63 - $80.22 $164,153 - $210,256
2,621 Added 72.58%
6,232 $466,000
Q4 2019

Feb 13, 2020

SELL
$61.62 - $67.78 $53,547 - $58,900
-869 Reduced 19.4%
3,611 $235,000
Q3 2019

Nov 13, 2019

SELL
$62.51 - $69.0 $29,442 - $32,499
-471 Reduced 9.51%
4,480 $284,000
Q2 2019

Aug 08, 2019

SELL
$61.87 - $69.38 $96,579 - $108,302
-1,561 Reduced 23.97%
4,951 $334,000
Q1 2019

May 16, 2019

SELL
$62.53 - $70.05 $102,236 - $114,531
-1,635 Reduced 20.07%
6,512 $423,000
Q4 2018

Feb 14, 2019

SELL
$60.54 - $79.0 $75,977 - $99,145
-1,255 Reduced 13.35%
8,147 $509,000
Q3 2018

Nov 14, 2018

BUY
$71.28 - $78.92 $670,174 - $742,005
9,402 New
9,402 $0
Q1 2018

May 11, 2018

SELL
$72.84 - $88.8 $617,464 - $752,757
-8,477 Closed
0 $0
Q4 2017

Feb 15, 2018

BUY
$71.15 - $83.52 $603,138 - $707,999
8,477
8,477 $607,000

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $118B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Financial Advocates Investment Management Portfolio

Follow Financial Advocates Investment Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Financial Advocates Investment Management, based on Form 13F filings with the SEC.

News

Stay updated on Financial Advocates Investment Management with notifications on news.